In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

98
In the Name of God In the Name of God Dr. A. Borjian Dr. A. Borjian Isfahan University of Isfahan University of Medical Science Medical Science

Transcript of In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Page 1: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

In the Name of GodIn the Name of God

Dr. A. BorjianDr. A. Borjian

Isfahan University of Isfahan University of Medical ScienceMedical Science

Page 2: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Pathologic fracturePathologic fracture

Page 3: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Benign tumorsBenign tumors

Malignant primary tumorsMalignant primary tumors

Mtastatic tumors Mtastatic tumors

Page 4: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Pathologic Fx:Pathologic Fx:

A pathologic Fx is defined, Fx occur in Abnormal BoneA pathologic Fx is defined, Fx occur in Abnormal Bone

Bone lack of normal biomechanical and viscoelastic Bone lack of normal biomechanical and viscoelastic

propertiesproperties

Weakened bone predispose the patient to failure in Weakened bone predispose the patient to failure in

normal activity or after minor trauma.normal activity or after minor trauma.

Page 5: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Pathologic fracture Pathologic fracture (Incidence)(Incidence)::

Osteoprosis most common condition Osteoprosis most common condition associated with pathologic Fxassociated with pathologic Fx

10 million American>50 have osteoprosis10 million American>50 have osteoprosis 34 million have osteomalacia and at risk 34 million have osteomalacia and at risk

devalping osteoporosisdevalping osteoporosis 1.5 million sustain P. Fx related to 1.5 million sustain P. Fx related to

osteoprosis eah yearosteoprosis eah year

Page 6: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Classification:Classification:

Intrinsic: Intrinsic: Osteopenia of osteogensis imperfect Osteopenia of osteogensis imperfect & Replacement of Bone with tumor& Replacement of Bone with tumor

Extrinsic: Lessen the inherent structural integrity Extrinsic: Lessen the inherent structural integrity of bone of bone Radiation or hole in bone Radiation or hole in bone

Localize Localize Bone cyst Bone cyst Generalize Generalize Osteopetrosis Osteopetrosis Correctable Correctable Rickets Rickets Un correctable Un correctable Metastatic cancer Metastatic cancer In normal bone In normal bone Vascular foramina Vascular foramina

Page 7: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Classification:Classification:

A: Correctable disease:A: Correctable disease: Renal osteodystrophyRenal osteodystrophy Hyper parathyroidismHyper parathyroidism OsteomalaciaOsteomalacia Disuse osteoprosisDisuse osteoprosis

Page 8: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Classification:Classification:

B: Uncorrectable disease:B: Uncorrectable disease: Osteogesis imperfectaOsteogesis imperfecta Polyostatic fibrous dysplasiaPolyostatic fibrous dysplasia Postmonoposal osteoprosisPostmonoposal osteoprosis Paget diseasePaget disease Osteo petrosisOsteo petrosis

Page 9: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Pathologic fracture:Pathologic fracture:

Fx callus may not form normally Fx callus may not form normally

healing slowlyhealing slowly

Increase incidence of nonunion & delay Increase incidence of nonunion & delay

unionunion

Page 10: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Diagnoses has been made on clinical Diagnoses has been made on clinical findingfinding HistoryHistory Physical examinationPhysical examination XrayXray Laboratory findingLaboratory finding Often the history is most helpfulOften the history is most helpful

Page 11: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Evaluation of a pediatric patientEvaluation of a pediatric patient

Age of patientAge of patient Location of the lesionLocation of the lesion

Epiphysis- metaphysis- diaphysisEpiphysis- metaphysis- diaphysis What is the lesion doing to the boneWhat is the lesion doing to the bone Zone of transitionZone of transition Pathern of lesionPathern of lesion

What is the bone doing to the lesionWhat is the bone doing to the lesion Periosteal responsePeriosteal response

Lytic- blastic- calsified- osified- ground glassLytic- blastic- calsified- osified- ground glass

Page 12: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Table 6-2Table 6-2

Page 13: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Table 6-3Table 6-3

Page 14: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Benign tumor Benign tumor

Page 15: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

U.B.C:U.B.C:

Radiolucent centric fluid filled cystic Radiolucent centric fluid filled cystic

70% proximal Humerus or femor, 70% proximal Humerus or femor,

75% present with pathologic Fx, 75% present with pathologic Fx,

if diameter of cyst 85% or more if diameter of cyst 85% or more

pathologic Fxpathologic Fx

Page 16: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Complication patho Fx:Complication patho Fx:

MalunionMalunion

Growth arrestGrowth arrest

Osteo necrosisOsteo necrosis

Collapse of articular surface Collapse of articular surface

Page 17: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Treatment:Treatment:

Undisplace FxUndisplace Fx

I.I. TractionTraction

II.II. Curtage & Bone graft (autograft or allograft)Curtage & Bone graft (autograft or allograft)

Displace Fx or Unstable FxDisplace Fx or Unstable Fx

Internal fixation + curettage & bone graftInternal fixation + curettage & bone graft

Page 18: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Classification for treatment of proximal Classification for treatment of proximal femur:femur:

Page 19: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 20: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 21: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 22: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 23: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Malignant tumors:Malignant tumors:

OsteosarcomaOsteosarcomaChondrosarcomaChondrosarcomalymphomalymphoma

Page 24: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

lymphomalymphoma

Page 25: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 26: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

LymphomaLymphoma Primary or secondaryPrimary or secondary

Sixth and seven decadesSixth and seven decades Male/female = 1.5/1Male/female = 1.5/1 Femor pelvic spine ribsFemor pelvic spine ribs

Page 27: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

LymphomaLymphoma

Chief complainChief complain

Localized painLocalized pain

SwellingSwelling

Nerve root or cord compression Nerve root or cord compression

Page 28: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

lymphomalymphoma

X ray X ray DiaphysialDiaphysial Illdefined Illdefined Bone distractionBone distraction Permeative apperancePermeative apperance Ticking of cortexTicking of cortex Periosteal reaction rarely seenPeriosteal reaction rarely seen

Page 29: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Radiogarph can be normal Radiogarph can be normal

Bone scanBone scan

MRIMRI

Page 30: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

StagingStaging CBCCBC Serom chemistrySerom chemistry Bone scanBone scan CT (chest abdomen pelvic)CT (chest abdomen pelvic) Bone marrow biopsyBone marrow biopsy

Page 31: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

patologypatology

Patology?Patology?

Page 32: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

PrognosisPrognosis

Primary 55% 5-year survivalPrimary 55% 5-year survival

Secondary <25%Secondary <25%

Page 33: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

TreatmentTreatment

ChemotherapyChemotherapy

RadiotherapyRadiotherapy

surgurysurgury

Page 34: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Case 1Case 1

Page 35: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 36: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 37: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 38: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 39: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 40: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 41: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 42: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 43: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 44: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 45: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 46: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Case 2Case 2

Page 47: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 48: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 49: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 50: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 51: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Case 3Case 3

Page 52: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 53: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 54: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Osteosarcoma:Osteosarcoma:

Osteosarcom & Ewing 10% pathologic Fx Osteosarcom & Ewing 10% pathologic Fx

Colse treatment in cast (After Biopsy)Colse treatment in cast (After Biopsy)

Neoadjuvan chemotherapyNeoadjuvan chemotherapy

Surgery (Limbsalvage or amputation)Surgery (Limbsalvage or amputation)

Page 55: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 56: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 57: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 58: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 59: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 60: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 61: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Chondrosarcoma:Chondrosarcoma:

Middle age or older adultMiddle age or older adult

Proximal femor most common for P. FxProximal femor most common for P. Fx

Serious mistake with metastatic carcinomaSerious mistake with metastatic carcinoma

Displace Fx Displace Fx amputation amputation

Page 62: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Chondrosarcoma:Chondrosarcoma:

Page 63: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 64: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 65: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 66: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 67: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

LymphomaLymphoma

Page 68: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Metastatic tumorMetastatic tumor

Metastatic carcinoma most common Metastatic carcinoma most common

malignancy treated by orthopedic surgeon malignancy treated by orthopedic surgeon

8000 sarcoma every year.8000 sarcoma every year.

1.3 million carcinoma 1.3 million carcinoma

50-80% carcinoma have bone metastase 50-80% carcinoma have bone metastase

at time of death.at time of death.

Page 69: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Metastatic tumor:Metastatic tumor:

BreastBreast

ProstateProstate

LungLung

KidneyKidney

ThyroidThyroid

Gastro intestinalGastro intestinal

Page 70: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Evaluation of patient with lytic bone Evaluation of patient with lytic bone lesionlesion

I.I. History:History:

Thyroid, breast or prostate noduleThyroid, breast or prostate nodule

II.II. Review of system:Review of system:

Gastrointestinal symptom, weight loss, flank pain, hematuriaGastrointestinal symptom, weight loss, flank pain, hematuria

III.III. Physical examination:Physical examination:

Lymph nocles, thyroid, breast, lungs, abdomen, prostate, teslicle and Lymph nocles, thyroid, breast, lungs, abdomen, prostate, teslicle and

rectumrectum

Page 71: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Evaluation of patient with lytic bone Evaluation of patient with lytic bone lesion:lesion:

IV.IV. Plain X-Ray: Plain X-Ray:

IV.IV. Chest, affected bone, humerus, pelvis, femur, spineChest, affected bone, humerus, pelvis, femur, spine

V.V. In affected bone (osteopenia, periostal reaction cortical In affected bone (osteopenia, periostal reaction cortical

thinning, looser line)thinning, looser line)

VI.VI. Breast & Prostate Breast & Prostate Blastic Blastic

VII.VII. Kidney & Thyroid Kidney & Thyroid Lytic Lytic

VIII.VIII. Lung Lung Mixed Mixed

IX.IX. Isolated avulsion Fx lesser trochanterIsolated avulsion Fx lesser trochanter

If lesion distal to elbow or knee lung cancer is most likely If lesion distal to elbow or knee lung cancer is most likely

primary lesionprimary lesion

Page 72: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Evaluation of patient with lytic bone Evaluation of patient with lytic bone lesionlesion

V.V. Bone scanBone scan 99 MTC99 MTC Pet Scan (Positron emission tomography) gold standard in Pet Scan (Positron emission tomography) gold standard in

metabolic imagingmetabolic imaging FDG (Fluorine- 18 deoxy glucose)FDG (Fluorine- 18 deoxy glucose) Pet CT. Scan (higher sensivity) & Specificity than pet scan for Pet CT. Scan (higher sensivity) & Specificity than pet scan for

detection of malignant bone lesion)detection of malignant bone lesion)

VI.VI. CT. Scan (Chest- Abdomen- Pelvis)CT. Scan (Chest- Abdomen- Pelvis)

VII.VII. Laboratory:Laboratory: CBC, ESR, Ca-P, UA, PSA, Alkphos, Immunoelectrotherosis, CBC, ESR, Ca-P, UA, PSA, Alkphos, Immunoelectrotherosis,

carcino embryonic antigen, CA 125, N-Telopeptide & C- carcino embryonic antigen, CA 125, N-Telopeptide & C- TelopheptideTelopheptide

Page 73: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 74: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 75: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 76: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 77: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Associated Medical problem: (Patient Associated Medical problem: (Patient with bone metastase):with bone metastase):

I.I. PainPain

II.II. Pathologic FxPathologic Fx

III.III. AnemiaAnemia

IV.IV. HypercalcemiaHypercalcemia

Page 78: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

When and how to biopsy:When and how to biopsy:

Staging studyStaging study

Needle or open incisionalNeedle or open incisional

a.a. Carcinoma from sarcomaCarcinoma from sarcoma

b.b. Contamination from open biopsyContamination from open biopsy

Biopsy of site un affected by FxBiopsy of site un affected by Fx

Even if a patient has a known history of Even if a patient has a known history of

carcinoma a biopsy of first sitecarcinoma a biopsy of first site

Page 79: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Impending pathologic Fx:Impending pathologic Fx:

Bone metastases are painfulBone metastases are painful

Fiddler:Fiddler:

If 50-75% cortical involvement If 50-75% cortical involvement moderate moderate

to severe pain to severe pain

After prophylactic internal fixation After prophylactic internal fixation no or no or

slight painslight pain

Page 80: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Goals of surgical treatment:Goals of surgical treatment:

Alleviate painAlleviate pain

Reduce narcotic useReduce narcotic use

Restore skeletal stabilityRestore skeletal stability

Regain functional independenceRegain functional independence

Page 81: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Impending fracture (Risk of Fx):Impending fracture (Risk of Fx):

Pain not respond to radiationPain not respond to radiation

Lesion greater than 2.5 cmLesion greater than 2.5 cm

Lesion destroy >50% cortexLesion destroy >50% cortex

Avulsion Fx of lessen trochonter Avulsion Fx of lessen trochonter

Page 82: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 83: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Scoring 7 or lower Scoring 7 or lower Irradiated Irradiated

Scoring 8 or higher Scoring 8 or higher prothylatic prothylatic

internal fixation before irradiationinternal fixation before irradiation

Page 84: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Benefit of fixation:Benefit of fixation:

Shorter hospitalization (average 2 days)Shorter hospitalization (average 2 days)

More immediate pain reliefMore immediate pain relief

Less blood lossLess blood loss

Return to premorbid functionReturn to premorbid function

Fewer hardware complicationFewer hardware complication

Page 85: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Treatment:Treatment:

A.A. General treatmentGeneral treatmentI.I. Cytotoxic agentCytotoxic agent

II.II. Hormone therapyHormone therapy

III.III. Radioactive iodineRadioactive iodine

IV.IV. Biphosthonate:Biphosthonate:a)a) Prevent new metastasePrevent new metastase

b)b) Inhibit osteoclast resorbtionInhibit osteoclast resorbtion

V.V. Most metastatic carcinoma sensitive Most metastatic carcinoma sensitive radiation except kidney cancerradiation except kidney cancer

Page 86: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Pathologic FxPathologic Fx

B.B. Local treatmentLocal treatment

1.1. Fixation stable Fixation stable

2.2. Tumor should be debulkTumor should be debulk

3.3. Reconstricle durableReconstricle durable

4.4. Cavity filled with PMMACavity filled with PMMA

Page 87: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Treatment:Treatment:

Pathologic Fx of femoral head & neck Pathologic Fx of femoral head & neck

rarely headrarely head

For head & neckFor head & neck cemented prosthesis cemented prosthesis

Hemi arthroplasty versus total hipHemi arthroplasty versus total hip

When adjacent lesion in subtrochantrick or When adjacent lesion in subtrochantrick or

proximal diaphysis proximal diaphysis long stem femoral long stem femoral

Page 88: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 89: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 90: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Treatment (Inter trochantric):Treatment (Inter trochantric):

DHS DHS high rate of failure even use PMMA high rate of failure even use PMMA

+ radiation+ radiation

Standard choice:Standard choice:

Cephalomedulary nail (Head & Neck Cephalomedulary nail (Head & Neck

bone)bone)

Prosthesis (Severe destruction)Prosthesis (Severe destruction)

Page 91: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 92: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.
Page 93: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Sub trochontric:Sub trochontric:

Subject to force of up 4-6 weight Subject to force of up 4-6 weight

Static locked intramedullaryStatic locked intramedullary

Extensive bone destruction Extensive bone destruction modular modular

proximal prosthesisproximal prosthesis

Page 94: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

ConclusionConclusion

The most common cause for a pathologic fracture is The most common cause for a pathologic fracture is osteoporosis or osteomalacia.osteoporosis or osteomalacia.

Patients with osteoporosis or osteomalacia require Patients with osteoporosis or osteomalacia require evaluation and management of the underlying disorder evaluation and management of the underlying disorder

Patients more than 45 years of age with a pathologic Patients more than 45 years of age with a pathologic fracture or lytic lesion are much more likely to have fracture or lytic lesion are much more likely to have metastatic bone disease than a primary bone tumor.metastatic bone disease than a primary bone tumor.

The prognosis for patients with metastatic bone disease The prognosis for patients with metastatic bone disease is improving because of early recognition and better is improving because of early recognition and better adjuvant treatment; therefore, many patients will live adjuvant treatment; therefore, many patients will live more than 2 years.more than 2 years.

Page 95: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

conclusionconclusion

Do not immediately assume that a lytic lesion or Do not immediately assume that a lytic lesion or pathologic fracture is from metastatic disease. A pathologic fracture is from metastatic disease. A thorough workup and possible biopsy are required.thorough workup and possible biopsy are required.

Prophylactic fixation for impending fractures from Prophylactic fixation for impending fractures from metastatic disease is technically easier for the surgeon metastatic disease is technically easier for the surgeon and allows a quicker patient recovery.and allows a quicker patient recovery.

The mirels scoring system is available to guide the The mirels scoring system is available to guide the treatment of an impending fracture from metastatic bone treatment of an impending fracture from metastatic bone disease.disease.

Page 96: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

conclusionconclusion

Femoral neck fractures from metastatic bone disease require a Femoral neck fractures from metastatic bone disease require a

cemented hip prosthesis, because internal fixation has a high rate of cemented hip prosthesis, because internal fixation has a high rate of

failure with disease progression.failure with disease progression.

When surgery is required for metastatic disease to the spine, When surgery is required for metastatic disease to the spine,

decompression and stabilization with internal fixation are generally decompression and stabilization with internal fixation are generally

necessary.necessary.

Surgical reconstruction for pathologic fractures should be durable Surgical reconstruction for pathologic fractures should be durable

enough to allow immediate weightbearing and last throughout the enough to allow immediate weightbearing and last throughout the

patient’s expected lifespan.patient’s expected lifespan.

Page 97: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

A pathologic fracture through a primary malignant bone tumor is A pathologic fracture through a primary malignant bone tumor is

treated much differently than a fracture through a metastatic lesion.treated much differently than a fracture through a metastatic lesion.

Treatment of a patients with pathologic fractures requires the Treatment of a patients with pathologic fractures requires the

presence of a multidisciplinary team composed of orthopaedic presence of a multidisciplinary team composed of orthopaedic

surgeons, medical oncologists, radiation oncologists, surgeons, medical oncologists, radiation oncologists,

endocrinologists, radiologists, pathologists, pain specialists, endocrinologists, radiologists, pathologists, pain specialists,

nutritionists, physical therapists, and psycholognutritionists, physical therapists, and psycholog

Page 98: In the Name of God Dr. A. Borjian Isfahan University of Medical Science.

Thank you for Thank you for your Attentionyour Attention